Search research articles
Contact Us
Filters
Showing results (181-190 of 184) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 184 results.
Obstetrics and Gynecology
|
January 12, 2019
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
Peter G Rose, James J Java, Ritu Salani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer
Robert L Hollis, Austin Miller, Heather A Lankes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 4, 2023
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Robert W Holloway, Premal Thaker, Alberto A Mendivil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2016
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Robert J Morgan, Deborah K Armstrong, Ronald D Alvarez, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 184) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 184 results.
Obstetrics and Gynecology
|
January 12, 2019
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
Peter G Rose, James J Java, Ritu Salani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2025
Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer
Robert L Hollis, Austin Miller, Heather A Lankes, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 4, 2023
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer
Robert W Holloway, Premal Thaker, Alberto A Mendivil, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2016
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Robert J Morgan, Deborah K Armstrong, Ronald D Alvarez, et al.
Page
of 19